Innovación en el manejo del dolor

1. Mercadante S. Buprenorfina y dolor relacionado con el cáncer. Buprenorfina, un analgésico excepcional. Farmacología y Aplicación Clínica. Ed. Keith Budd and Robert Raffa 2006. Cap 7.

2. Budd K. High Dose Buphrenorphine for postoperative analgesia. Anaesthesia 1981;36:900-903.

3. Budd K. Buphrenorphine and the transdermal system. The ideal match in pain management. Int J Clin Prac 2003;S 133:9-14.

4. Budd K. Experience with partial agonists in the treatment of cancer pain. In: Doyle D (Ed). Opioid in the Treatment of Cancer Pain. London, Royal Society of Medicine, 1990:51-55.

5. Walsh S, Preston KL, Bigelow GE, Stitzer ML. Acute administration of buprenorphine in humans: Partial agonist and lockade effects. J Pharmacol Exp Ther 1995;274:361-372.

6. Koegel B, Christoph T, Strassburger W,Friderichs E. Interaction of μ opiod receptor agonists and antagonist with the analgesic effect of Buprenorphine in mice. Eur J Pain 2005:599-611.

7. Lewis JW. Buprenorphine. Drug Alcohol Depend 1985;14:363-372. http://dx.doi.org

8. Rance MJ, Shillingford JS. The role of the gut in the metabolism of strong analgesics. Biochem Pharmacol 1976;25:735-741.

9. Rance MJ Shilingford JS. The metabolism of phenolic opiates by rat intestine. Xenobiotica 1977;67:529-536.

10. Bartleson JD. Evidence for and against the use of opioid analgesics for chronic non malignant low back pain: a review. Pain Med 2002;3:260-271.

11. Kalso E. Route of opioid administration: does it make a difference? In: Kalso E, McQuay Hj, Wiesenfeld- Hallin Z, editors. Opioid sensitivity of chronic non cancer pain. Progress in pain research and management, vol. 14. IASP Press, Seattle, 1999:117.

12. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotesis derived from studies of opioid infusions. Pain 1990;43:273-286.

13. Robinson SE. Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction. CNS Drug Rev 2002;8:377-390.

14. Christoph T, Kogel B, Schiene K, Meen M, de Vry J, Friderichs E. Broad analgesic profile of buprenophine in rodent models of acute and chronic pain. Eur J Pharmacol 2005;507:87-98.